Answers are grounded in this paper and cite their sources.
Case report shows Vitamin E reduces sweating in major depressive disorder patients on venlafaxine, indicating a low-risk complementary treatment.
Excessive sweating is a common side effect of antidepressants, affecting approximately 22% of patients. Antidepressant‐induced excessive sweating (ADIES) can significantly impair quality of life and medication adherence. This case report explores the use of Vitamin E as a novel adjunct treatment for ADIES. A woman in her 30s with major depressive disorder experienced significant improvement in depressive symptoms with venlafaxine but developed distressing night sweats at higher doses. Given the patient's reluctance to switch to a different antidepressant and to reduce polypharmacy, a trial of over‐the‐counter Vitamin E was initiated based on its prior evidence in managing hot flashes in postmenopausal women. After 3 months, the patient reported a significant reduction in sweating, as measured by validated symptom severity scales (CGI‐S and HDSS). The case highlights Vitamin E as a potentially effective, low‐risk, and accessible option for ADIES, especially for patients at risk for polypharmacy. While larger studies are needed, Vitamin E may offer a simple strategy for improving quality of life and medication adherence.
No takes yet. Share an insight, caveat, or question.
Nazir et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: